Anti-Cancer Agent, Herceptin®, Filed for Additional Dosage and Administration for Postoperative Adjuvant Chemotherapy in Breast Cancer By “New Drug Application Based on Evidence in the Public Domain”
Feb 07, 2013
Anti-Cancer Agent, Herceptin®, Filed for Additional Dosage and Administration for Postoperative Adjuvant Chemotherapy in Breast Cancer By “New Drug Application Based on Evidence in the Public Domain”
Anti-Cancer Agent, Herceptin®, Filed for Additional Dosage and Administration for Postoperative Adjuvant Chemotherapy in Breast Cancer By “New Drug Application Based on Evidence in the Public Domain”
